Patents by Inventor Paolo Rovero

Paolo Rovero has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOACTIVE PEPTIDES AND COMPOSITIONS COMPRISING THEM
    Publication number: 20220227807
    Abstract: The present invention relates to bioactive peptides and to the cosmeceutical compositions containing them, useful for the prevention and treatment of the signs of skin aging, such as wrinkles, fine lines and loss of firmness and elasticity of the skin, thanks to their efficacy in the protection of the dermal collagen.
    Type: Application
    Filed: June 5, 2020
    Publication date: July 21, 2022
    Applicants: ESPIKEM S.R.L., UNIVERSITA DEGLI STUDI DI FIRENZE
    Inventors: Fosca ERRANTE, Lisa GIOVANNELLI, Anna Maria PAPINI, Paolo ROVERO
  • METHOD FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS
    Publication number: 20140106381
    Abstract: The present invention refers to the use of citrullinated synthetic peptides for the diagnosis of rheumatoid arthritis (RA).
    Type: Application
    Filed: May 24, 2012
    Publication date: April 17, 2014
    Applicant: TOSCANA BIOMARKERS S.R.L.
    Inventors: Paola Migliorini, Federico Pratesi, Mario Chelli, Francesco Lolli, Ilaria Paolini, Anna Maria Papini, Maria Claudia Alcaro, Paolo Rovero
  • HISTONE CITRULLINATED PEPTIDES AND USES THEREOF
    Publication number: 20130115636
    Abstract: The present invention refers to citrullinated synthetic peptides derived from the histone H4 protein and their use in the diagnosis of autoimmune diseases,particularly Rheumatoid Arthritis (RA).
    Type: Application
    Filed: June 30, 2011
    Publication date: May 9, 2013
    Applicant: TOSCANA BIOMARKERS S.R.L.
    Inventors: Paola Migliorini, Federico Pratesi, Marío Chelli, Francesco Lolli, Ilaria Paolini, Anna Maria Papini, Maria Claudía Alcaro, Paolo Rovero
  • DETECTION OF ANTI-RIBOSOMAL P PROTEIN ANTIBODIES BY MEANS OF SYNTHETIC PEPTIDES
    Publication number: 20110028409
    Abstract: The present invention refers peptides and methods for the identification of diagnostic antibodies in auto-immune diseases such as Systemic Lupus Erythematosus (SLE), and therefore useful tools for diagnosis or therapeutic treatment of SLE.
    Type: Application
    Filed: July 23, 2010
    Publication date: February 3, 2011
    Applicant: TOSCANA BIOMARKERS S.R.L.
    Inventors: Federico PRATESI, Maria Claudia ALCARO, Mario CHELLI, Paolo FANTINI, Francesco LOLLI, Ilaria PAOLINl, Anna Maria PAPINI, Paolo ROVERO, Paola MIGLIORINI
  • Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
    Patent number: 7037893
    Abstract: Glycopeptides capable of identifying multiple sclerosis antibodies, and therefore useful as diagnostic tools or for the treatment of said pathology are described.
    Type: Grant
    Filed: June 19, 2002
    Date of Patent: May 2, 2006
    Assignee: Universita' Degli Studi Di Firenze
    Inventors: Anna Maria Papini, Mario Chelli, Paolo Rovero, Francesco Lolli
  • Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis
    Publication number: 20040235713
    Abstract: Glycopeptides capable of identifying multiple sclerosis antibodies, and therefore useful as diagnostic tools or for the treatment of said pathology are described.
    Type: Application
    Filed: December 22, 2003
    Publication date: November 25, 2004
    Inventors: Anna Maria Papini, Mario Chelli, Paolo Rovero, Francesco Lolli
  • Synthetic peptide antagonists of neurokinin A, salts thereof and respective preparation processes
    Patent number: 5128447
    Abstract: A synthetic peptide corresponding to the following formula:X--Asp--Y--DTrp--Val--DTrp--Z--K--NH.sub.2where:X=H, Arg, DArg, Lys, DLys, Thr, DThrY=Tyr, Trp, DTrp, Ser, MetZ=Trp, DTrpK=Arg, Phe, DTrp, Tyr, Metand pharmaceutically acceptable salts thereof with organic and inorganic acids as competitive antagonists against neurokinin A (NK-2 receptor).
    Type: Grant
    Filed: May 24, 1990
    Date of Patent: July 7, 1992
    Assignee: A. Menarini Industrie Farmaceutiche Riunite S.r.l.
    Inventors: Paolo Rovero, Vittorio Pestellini, Carlo A. Maggi, Riccardo Patacchini, Paolo Santicioli, Sandro Giuliani, Alberto Meli